Invention Grant
- Patent Title: Adjuvant composition containing citrulline
-
Application No.: US15168839Application Date: 2016-05-31
-
Publication No.: US10556005B2Publication Date: 2020-02-11
- Inventor: Chikateru Nozaki , Kazuyoshi Kaminaka , Junichi Matsuda
- Applicant: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
- Applicant Address: JP Kumamoto-shi
- Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
- Current Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
- Current Assignee Address: JP Kumamoto-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2011-053658 20110311
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K39/39 ; A61K39/00 ; A61K39/12 ; A61K39/145

Abstract:
A novel adjuvant composition is provided that is excellent in safety and convenience as compared to the conventional adjuvant such as Alum. An adjuvant composition comprising citrullines, which are water soluble substance present in the living body, and/or a salt thereof; a vaccine composition comprising said adjuvant composition and an antigen; a process for preparing said adjuvant composition and said vaccine composition; and a method for administering said adjuvant composition and said vaccine composition are provided.
Public/Granted literature
- US20170239348A1 ADJUVANT COMPOSITION CONTAINING CITRULLINE Public/Granted day:2017-08-24
Information query